We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Register for real-time alerts, custom portfolio, and market movers
The current ACL market cap is 742.75M. The company's latest EPS is AUD 0.1186 and P/E is 31.03.
| Year End 30 June 2024 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| AUD (AUD) | AUD (AUD) | AUD (AUD) | AUD (AUD) | AUD (AUD) | |
| Total Revenue | 0 | 644.67M | 997.17M | 704.76M | 697.54M |
| Operating Income | 0 | 108.55M | 266.6M | 61.99M | 52.91M |
| Net Income | 0 | 60.37M | 178.24M | 35.9M | 23.93M |
| Year End 30 June 2024 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| AUD (AUD) | AUD (AUD) | AUD (AUD) | AUD (AUD) | AUD (AUD) | |
| Total Assets | 406.7M | 484.1M | 628.04M | 578.91M | 593.06M |
| Total Liabilities | 359.6M | 402.19M | 395.49M | 406.24M | 415.3M |
| Total Equity | 47.1M | 81.91M | 232.56M | 172.67M | 177.77M |
| Year End 30 June 2024 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| AUD (AUD) | AUD (AUD) | AUD (AUD) | AUD (AUD) | AUD (AUD) | |
| Operating | N/A | 153.86M | 284.09M | 143.68M | 159.59M |
| Investing | N/A | -6.08M | -72.04M | -12.18M | -7.25M |
| Financing | N/A | -147.37M | -220.91M | -137.88M | -146.14M |
| Market Cap | 742.75M |
| Price to Earnings Ratio | 31.03 |
| Price to Sales Ratio | 1.06 |
| Price to Cash Ratio | 28.42 |
| Price to Book Ratio | 4.18 |
| Dividend Yield | - |
| Shares Outstanding | 201.83M |
| Average Volume (1 week) | 424.52k |
| Average Volume (1 Month) | 501.49k |
| 52 Week Change | 26.03% |
| 52 Week High | 3.855 |
| 52 Week Low | 2.14 |
| Spread (Intraday) | 0.08 (2.13%) |
| Company Name | Australian Clinical Labs Limited |
| Address |
1868-1892 dandenong road melbourne, victoria 3168 |
| Website | https://clinicallabs.com.au/offer |
| Industry | medical laboratories (8071) |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Hot Features
Premium
